A
Autoliv, Inc.
ALV · Consumer Cyclical
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
Safety's Cash Machine Priced Like a Business in Decline
The market is discounting Autoliv as a China loser, but the Q4 data tells the opposite story — Chinese OEM order intake surging nearly forty percent and now comprising a third of global wins. The bear and bull cases are running simultaneously, and the stock price only reflects the bear.
Flowly Score
Apr 16 Close
+107%$111.33
Fair Value
$230.00
67
Strongat $111.33
Business Strength7/10
A regulatory-mandated duopoly with multi-year design-win lock-in and ROIC now running well above industrial peers — this is a harvesting machine, not a compounder. The moat is real but faces a genuine stress test as Chinese OEMs globalize with domestic supply chains in tow.
Financial Resilience7/10
Cash conversion is unusually clean for a manufacturer — OCF consistently running above net income for years rules out earnings quality concerns. The Altman Z in the gray zone and an 18% debt increase in the latest year deserve watching, but FCF generation now covers reinvestment and returns with room to spare.
Growth & Trajectory5/10
Revenue growth is barely a storyline — what's real is that earnings are dramatically outpacing sales, driven by buybacks compressing the share count on top of genuine margin recovery. The 2026 guide for flat organic sales with manageable margin compression is honest, but the Chinese OEM order intake surge is the one forward-looking data point that materially upgrades the long-term picture.
Valuation8/10at $109.45
A mid-cycle P/E barely above ten times and a free cash flow yield approaching eight percent for a business with a regulatory mandate and no credible existential threat is mispricing — the multiple reflects cyclical auto pessimism, not permanent impairment. Even the pessimistic DCF scenario lands well above the current price, suggesting the downside is well-cushioned.
Risk5/10
The existential risks are overblown — airbags and seatbelts survive every powertrain transition — but the China displacement story is concrete and accelerating: domestic Chinese safety suppliers have closed the technical gap, and if BYD and Geely systematically route content to local alternatives while expanding globally, Autoliv loses on volume and mix simultaneously. Customer concentration among a handful of global OEMs is the secondary risk, adding leverage to any pricing renegotiation.
Autoliv is what happens when a dominant industrial franchise gets lumped in with the broader auto sector malaise and re-rated indiscriminately. The business has done something genuinely rare for a manufacturer: it rebuilt ROIC after a brutal inflationary shock, normalized a heavy capex cycle, and exited 2025 with record free cash flow — all while the stock sat at a multiple more appropriate for a structurally declining business. At current prices you are buying a regulatory-mandated duopoly, embedded in global vehicle platforms for the next decade, at a cash flow yield that would imply no growth forever — which is wrong even on conservative assumptions. The trajectory is quietly improving on the margin that matters most. The Chinese OEM penetration story is the pivotal development: three years ago, Autoliv was viewed as a legacy Western supplier watching China's domestic market drift toward local alternatives. The Q4 evidence — forty percent Chinese OEM revenue growth, a first-ever order for European production with a Chinese OEM, and Chinese brands now representing nearly half of China sales — suggests the company has adapted faster than consensus assumes. Combine that with regulatory ratcheting in India and South America driving content-per-car expansion, and the growth picture is more interesting than the flat organic guide implies. The single biggest risk is not autonomous vehicles, not electrification, and not recession — it is a specific scenario where Chinese-owned OEMs become the dominant global volume platform while simultaneously deepening relationships with domestic Chinese safety suppliers, stranding Autoliv with flat-to-declining volumes in its highest-growth geography and forcing margin compression to defend share. That scenario is possible but not inevitable; the Q4 order intake data argues against it. Sizing that risk correctly, rather than treating it as a foregone conclusion, is where the analytical edge lives.